Home › Trial NCT05802056
Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis
- Trial IDNCT05802056
- StatusActive Not Recruiting
- PhasePhase 1
- Study typeInterventional
- SponsorMayo Clinic
- Enrollment15
- Start date2023-11-29
- ConditionsClinical Stage IV Gastric Cancer AJCC v8 · Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Metastatic Gastric Carcinoma · Metastatic Malignant Neoplasm in the Peritoneum
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.